Market research
VXL.V Vaxil Bio Ltd
V CAD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 637K
- P/E ratio
- 0.89
- Dividend yield
- Not available
- Beta
- -0.88
Community
Investor discussion
1 comment
Sign in to join the VXL.V discussion.
5 years, 5 months ago
Vaxil Bio Ltd is currently in a long term downtrend where the price is trading 44.7% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Vaxil Bio Ltd's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 51.2% to $-313K since the same quarter in the previous year.
Finally, its free cash flow fell by 148.6% to $-261K since the same quarter in the previous year.
Based on the above factors, Vaxil Bio Ltd gets an overall score of 1/5.